• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PLUROMED INC. LEGOO (LEGOO)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PLUROMED INC. LEGOO (LEGOO) Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Type  Death  
Event Description
This solicited device case from (b)(6) was received on (b)(6) 2014 via conference abstract: wimmergg, bouchot o, verhoye j, perrault lp, boergermann j, diegeler a et al.Randomised clinical trail comparing a thermosensitive polymer (legoo) versus conventional vessel loops for temporary coronary artery occlusion during off-pump coronary artery bypass surgery.Twenty-fourth annual meeting of the european association for cardio-thoracic surgery, eacts 2010; 2010 sep 11-15; geneva, switzerland.Interact.Cardiovasc.Thorac.Surg.2010.2010; 11 suppl 2:s116-17.From this publication, one additional case reported was: (b)(6)(cluster case).This case concerns a patient (demographics not provided) who died (unknown cause) after receiving treatment with legoo.The patient's medical history, concomitant medication and past drugs were not reported.On an unknown date, the patient was undergoing off pump coronary artery bypass surgery and was randomized to use legoo (form, route, dose, frequency, batch/lot number and expiration date: not reported) into unspecified vessel for temporary vascular occlusion.On an unknown date, after unknown latency, the patient died due to unknown cause.It was unknown if autopsy was done.Reporter causality: related (adverse event to legoo).Company causality: associated.A pharmaceutical technical complaint (ptc) was initiated and ptc results were pending for the same.
 
Manufacturer Narrative
Pharmacovigilance comment: sanofi company comment dated 28-nov-2014: this is an initial literature case concerning a patient in whom legoo was used for temporary vascular occlusion and died after coronary artery bypass surgery.Evaluating the indication for use the role of legoo cannot be completely ruled out for the causation of event.However no information regarding the underlying cocurrent medical conditions, the post-operative condition of the patient and complete lack of information regarding cause of death and autopsy details makes the complete medical assessment of the case difficult.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEGOO (LEGOO)
Manufacturer (Section D)
PLUROMED INC.
woburn MA
Manufacturer Contact
kristen sharma, md
55 corporate drive
mail stop: 55c-235a
bridgewater, NJ 08807
9089812784
MDR Report Key4307587
MDR Text Key18924651
Report Number3008867907-2014-65099
Device Sequence Number1
Product Code OBC
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Literature,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 11/23/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CON MEDS = UNKNOWN; PREV MEDS = UNKNOWN
Patient Outcome(s) Death;
-
-